{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:40:35Z","timestamp":1760838035701,"version":"build-2065373602"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.bmc.2022.117042","type":"journal-article","created":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T19:40:06Z","timestamp":1664912406000},"page":"117042","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Fluorophenylalkyl-substituted cyanoguanidine derivatives as bacteria-selective MATE transporter inhibitors for the treatment of antibiotic-resistant infections"],"prefix":"10.1016","volume":"74","author":[{"given":"Susumu","family":"Shinya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukiko","family":"Karuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Tarui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyuki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Otsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Omote","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2022.117042_b0005","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Antimicrobial Resistance Collaborators","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.bmc.2022.117042_b0010","unstructured":"Tackling drug-resistant infections globally final report and recommendations \/ the Review on Antimicrobial Resistance chaired by Jim O'Neill. Wellcome Collection. https:\/\/wellcomecollection.org\/works\/thvwsuba (accessed May 30, 2022)."},{"key":"10.1016\/j.bmc.2022.117042_b0015","unstructured":"Antimicrobial resistance surveillance in Europe 2022 \u2013 2020 data (2022) https:\/\/www.euro.who.int\/en\/health-topics\/disease-prevention\/antimicrobial-resistance\/publications\/2022\/antimicrobial-resistance-surveillance-in-europe-2022-2020-data-2022 (accessed May 30, 2022). doi:10.2900\/112339."},{"key":"10.1016\/j.bmc.2022.117042_b0020","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s00239-019-09914-3","article-title":"Antimicrobial resistance in bacteria mechanisms, evolution, and persistence","volume":"88","author":"Christaki","year":"2020","journal-title":"J Mol Evol"},{"key":"10.1016\/j.bmc.2022.117042_b0025","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.bbrc.2014.05.090","article-title":"Bacterial multidrug efflux pumps mechanisms, physiology and pharmacological exploitations","volume":"453","author":"Sun","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bmc.2022.117042_b0030","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1080\/07853890701195262","article-title":"Efflux pumps as antimicrobial resistance mechanisms","volume":"39","author":"Poole","year":"2007","journal-title":"Ann Med"},{"key":"10.1016\/j.bmc.2022.117042_b0035","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/jac\/dkv316","article-title":"Efflux pump inhibitors targeting mycobacterial efflux systems to enhance TB therapy","volume":"71","author":"Pule","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bmc.2022.117042_b0040","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3390\/antibiotics8040229","article-title":"Effectiveness of Efflux Pump Inhibitors as Biofilm Disruptors and Resistance Breakers in Gram-Negative (ESKAPEE) Bacteria","volume":"8","author":"Reza","year":"2019","journal-title":"Antibiotics"},{"key":"10.1016\/j.bmc.2022.117042_b0045","doi-asserted-by":"crossref","first-page":"223","DOI":"10.4161\/viru.23724","article-title":"Role of efflux pumps in the antibiotic resistance of bacteria embedded in a biofilm","volume":"4","author":"Soto","year":"2013","journal-title":"Virulence"},{"key":"10.1016\/j.bmc.2022.117042_b0050","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1046\/j.1365-2958.1999.01162.x","article-title":"The multidrug efflux protein NorM is a prototype of a new family of transporters","volume":"31","author":"Brown","year":"1999","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.bmc.2022.117042_b0055","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.tips.2006.09.001","article-title":"The MATE proteins as fundamental transporters of metabolic and xenobiotic organic cations","volume":"27","author":"Omote","year":"2006","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.bmc.2022.117042_b0060","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.bbapap.2008.11.012","article-title":"Multidrug efflux transporters in the MATE family","volume":"1794","author":"Kuroda","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.bmc.2022.117042_b0065","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/jac\/dki171","article-title":"Efflux-mediated antimicrobial resistance","volume":"56","author":"Poole","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bmc.2022.117042_b0070","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/j.1348-0421.2003.tb03467.x","article-title":"Molecular cloning and characterization of the HmrM multidrug efflux pump from Haemophilus influenzae Rd","volume":"47","author":"Xu","year":"2003","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.bmc.2022.117042_b0075","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/jac\/dkf024","article-title":"Role of newer fluoroquinolones in lower respiratory tract infections","volume":"49","author":"Lode","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bmc.2022.117042_b0080","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.3201\/eid0911.030176","article-title":"Levofloxacin treatment failure in Haemophilus influenzae pneumonia","volume":"9","author":"Bastida","year":"2003","journal-title":"Emerging Infectious Dis"},{"key":"10.1016\/j.bmc.2022.117042_b0085","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1128\/AAC.04005-14","article-title":"Molecular characterization of fluoroquinolone resistance in nontypeable Haemophilus influenzae clinical isolates","volume":"59","author":"Puig","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2022.117042_b0090","doi-asserted-by":"crossref","first-page":"17923","DOI":"10.1073\/pnas.0506483102","article-title":"A human transporter protein that mediates the final excretion step for toxic organic cations","volume":"102","author":"Otsuka","year":"2005","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.bmc.2022.117042_b0095","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1053\/j.ajkd.2015.08.029","article-title":"Future Avenues to Decrease Uremic Toxin Concentration","volume":"67","author":"Vanholder","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.bmc.2022.117042_b0100","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/toxsci\/kfz093","article-title":"Relationship of MATE1 Inhibition and Cytotoxicity in Nephrotoxicity application for Safety Evaluation in Early Drug Discovery","volume":"170","author":"Tohyama","year":"2019","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.bmc.2022.117042_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116580","article-title":"Potentiating the intracellular killing of Staphylococcus aureus by dihydroquinazoline analogues as NorA efflux pump inhibitor","volume":"54","author":"Deka","year":"2022","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2022.117042_b0110","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.bmc.2018.12.008","article-title":"Synthesis of amides from (E)-3-(1-chloro-3,4-dihydronaphthalen-2-yl)acrylic acid and substituted amino acid esters as NorA efflux pump inhibitors of Staphylococcus aureus","volume":"27","author":"Rath","year":"2019","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2022.117042_b0115","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1016\/j.bmc.2019.07.006","article-title":"Thiazolidinedione and thiazole derivatives potentiate norfloxacin activity against NorA efflux pump over expression in Staphylococcus aureus 1199B strains","volume":"27","author":"Pereira","year":"2019","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2022.117042_b0120","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1248\/cpb.c21-00429","article-title":"Importance of the Azole Moiety of Cimetidine Derivatives for the Inhibition of Human Multidrug and Toxin Extrusion Transporter 1 (hMATE1)","volume":"69","author":"Shinya","year":"2021","journal-title":"Chem Pharm Bull"},{"key":"10.1016\/j.bmc.2022.117042_b0125","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1021\/jm040835a","article-title":"Derivation and validation of toxicophores for mutagenicity prediction","volume":"48","author":"Kazius","year":"2005","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2022.117042_b0130","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1021\/ci300245q","article-title":"ToxAlerts a Web server of structural alerts for toxic chemicals and compounds with potential adverse reactions","volume":"52","author":"Sushko","year":"2012","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.bmc.2022.117042_b0135","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1128\/AAC.45.12.3341-3346.2001","article-title":"A MATE family multidrug efflux transporter pumps out fluoroquinolones in Bacteroides thetaiotaomicron","volume":"45","author":"Miyamae","year":"2001","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.bmc.2022.117042_b0140","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1128\/AAC.42.7.1778","article-title":"NorM, a putative multidrug efflux protein, of Vibrio parahaemolyticus and its homolog in Escherichia coli","volume":"42","author":"Morita","year":"1998","journal-title":"Antimicrob Agents Chemother."},{"issue":"7873","key":"10.1016\/j.bmc.2022.117042_b0145","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature."},{"key":"10.1016\/j.bmc.2022.117042_b0150","unstructured":"Uniprot, https:\/\/www.uniprot.org\/ (accessed May 30, 2022)."},{"key":"10.1016\/j.bmc.2022.117042_b0155","doi-asserted-by":"crossref","unstructured":"Mirdita M, Sch\u00fctze K, Moriwaki Y, Heo L, Ovchinnikov S, Steinegger M. ColabFold - Making protein folding accessible to all. bioRxiv, 2021 https:\/\/www.biorxiv.org\/content\/10.1101\/2021.08.15.456425v2.","DOI":"10.1101\/2021.08.15.456425"},{"issue":"3","key":"10.1016\/j.bmc.2022.117042_b0160","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1021\/ci100436p","article-title":"FRED pose prediction and virtual screening accuracy","volume":"51","author":"McGann","year":"2011","journal-title":"J Chem Inf Model."},{"key":"10.1016\/j.bmc.2022.117042_b0165","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.acthis.2018.03.007","article-title":"Current methodology of MTT assay in bacteria - a review","volume":"120","author":"Grela","year":"2018","journal-title":"Acta. Histochem."},{"key":"10.1016\/j.bmc.2022.117042_b0170","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1128\/JB.184.2.572-576.2002","article-title":"VmrA, a member of a novel class of Na(+)-coupled multidrug efflux pumps from Vibrio parahaemolyticus","volume":"184","author":"Chen","year":"2002","journal-title":"J Bacteriol."},{"key":"10.1016\/j.bmc.2022.117042_b0175","unstructured":"CLSI, Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically Approved Standard - Tenth Edition. CLSI document M07-A10 2015 Vol. 35. ISBN 1562389874 9781562389871."}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089622004357?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089622004357?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:18:45Z","timestamp":1760836725000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089622004357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":35,"alternative-id":["S0968089622004357"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2022.117042","relation":{},"ISSN":["0968-0896"],"issn-type":[{"type":"print","value":"0968-0896"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fluorophenylalkyl-substituted cyanoguanidine derivatives as bacteria-selective MATE transporter inhibitors for the treatment of antibiotic-resistant infections","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2022.117042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117042"}}